Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01083563 · ClinicalTrials.gov registry record

Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy

A clinical trial, sponsored by University of Rochester.

Terminated
Registry status
7
Enrollment target

NCT01083563: Clinical Trial study, sponsored by University of Rochester.

NCT01083563 is a clinical trial that was terminated before completion, run by University of Rochester. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01083563 was terminated before completion, sponsored by University of Rochester.

TERMINATED
Registry status
7 participants
Enrollment target

Study Summary

The purpose of this study is to examine the effect of anti-TNF therapy on rheumatoid arthritis using magnetic resonance imaging (MRI) and ultrasound imaging. Anti-TNF therapies include a group of medications such as Enbrel, Remicade and Humira that affect your body's inflammatory response. These medications are routinely prescribed for the treatment of rheumatoid arthritis.

Primary Outcome

To examine the morphologic and functional relationship between the draining PLN and synovial inflammation in the knee joints of RA patients before and after therapy with TNF antagonists or B cell depletion therapy via MRI and Doppler ultrasound.

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2009-07
Est. Completion 2015-03
University of Rochester

636 total trials

Why NCT01083563 stopped before completion

NCT01083563 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01083563 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01083563 about?

NCT01083563 is a clinical study titled "Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy". The purpose of this study is to examine the effect of anti-TNF therapy on rheumatoid arthritis using magnetic resonance imaging (MRI) and ultrasound imaging. Anti-TNF therapies include a group of medications such as Enbrel, Remicade and Humira that affect your body's inflammatory response. These me...

What is the current status of trial NCT01083563?

This trial is currently terminated. The enrollment target is 7 participants. The study started on 2009-07. Estimated completion is 2015-03.

Who is sponsoring clinical trial NCT01083563?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01083563, the US trial registry maintained by the National Library of Medicine. NCT01083563 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.